These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16150538)

  • 1. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy.
    Moghtaderi A; Bakhshipour A; Rashidi H
    Clin Neurol Neurosurg; 2006 Jul; 108(5):477-81. PubMed ID: 16150538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the four simple methods in the diagnosis of diabetic peripheral neuropathy].
    Jia WP; Shen Q; Bao YQ; Lu JX; Li M; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2707-10. PubMed ID: 17199983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparison of clinical effectiveness of different neuropathy scoring systems in screening asymptomatic diabetic peripheral neuropathy].
    Hu H; Li H; Zheng FP; Cheng Y; Miao J; Zhang W
    Zhonghua Nei Ke Za Zhi; 2012 Jan; 51(1):13-7. PubMed ID: 22490752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications.
    Herman WH; Pop-Busui R; Braffett BH; Martin CL; Cleary PA; Albers JW; Feldman EL;
    Diabet Med; 2012 Jul; 29(7):937-44. PubMed ID: 22417277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of obesity on the assessment of diabetic peripheral neuropathy: a comparison of Michigan patient version test and Michigan physical assessment.
    Boyraz O; Saracoglu M
    Diabetes Res Clin Pract; 2010 Dec; 90(3):256-60. PubMed ID: 20943282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy.
    Lunetta M; Le Moli R; Grasso G; Sangiorgio L
    Diabetes Res Clin Pract; 1998 Mar; 39(3):165-72. PubMed ID: 9649948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and Reliability of the Portuguese Version of the Michigan Neuropathy Screening Instrument.
    Barbosa M; Saavedra A; Severo M; Maier C; Carvalho D
    Pain Pract; 2017 Apr; 17(4):514-521. PubMed ID: 27538385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of symptoms of sensorimotor and autonomic neuropathy in Type 1 and Type 2 diabetic subjects.
    Kästenbauer T; Irsigler P; Sauseng S; Grimm A; Prager R
    J Diabetes Complications; 2004; 18(1):27-31. PubMed ID: 15019596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.
    Bastyr EJ; Price KL; Bril V;
    Clin Ther; 2005 Aug; 27(8):1278-94. PubMed ID: 16199253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Diagnostic Value of Neuropathy Symptom and Change Score, Neuropathy Impairment Score and Michigan Neuropathy Screening Instrument for Diabetic Peripheral Neuropathy.
    Xiong Q; Lu B; Ye H; Wu X; Zhang T; Li Y
    Eur Neurol; 2015; 74(5-6):323-7. PubMed ID: 26684759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study.
    Papanas N; Giassakis G; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Piperidou H; Maltezos E
    J Diabetes Complications; 2007; 21(6):353-8. PubMed ID: 17967706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nomogram-based diabetic sensorimotor polyneuropathy severity prediction using Michigan neuropathy screening instrumentations.
    Haque F; Ibne Reaz MB; Chowdhury MEH; Md Ali SH; Ashrif A Bakar A; Rahman T; Kobashi S; Dhawale CA; Sobhan Bhuiyan MA
    Comput Biol Med; 2021 Dec; 139():104954. PubMed ID: 34715551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is asymptomatic peripheral neuropathy present in Nigerian diabetic patients? An assessment using the United Kingdom screening test (UKST) and bio-thesiometry.
    Oguejiofor OC; Oli JM; Ajaero CN; Odenigbo CU; Odike MA
    Afr J Med Med Sci; 2008 Sep; 37(3):265-71. PubMed ID: 18982820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different screening tests for detecting diabetic foot neuropathy.
    Forouzandeh F; Aziz Ahari A; Abolhasani F; Larijani B
    Acta Neurol Scand; 2005 Dec; 112(6):409-13. PubMed ID: 16281925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUDOSCAN in Combination with the Michigan Neuropathy Screening Instrument Is an Effective Tool for Screening Diabetic Peripheral Neuropathy.
    Oh TJ; Song Y; Jang HC; Choi SH
    Diabetes Metab J; 2022 Mar; 46(2):319-326. PubMed ID: 34525791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of peripheral neuropathy and painful peripheral neuropathy in Turkish diabetic patients.
    Erbas T; Ertas M; Yucel A; Keskinaslan A; Senocak M;
    J Clin Neurophysiol; 2011 Feb; 28(1):51-5. PubMed ID: 21221008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision of Michigan Neuropathy Screening Instrument (MNSI) Tool for the Diagnosis of Diabetic Peripheral Neuropathy Among People with Type 2 Diabetes-A Study from South India.
    Viswanathan V; Ahmed Khan B; Nachimuthu S; Kumpatla S
    Int J Low Extrem Wounds; 2023 Mar; ():15347346231163209. PubMed ID: 36924005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translation, validation, and diagnostic accuracy of the Arabic version of the Michigan neuropathy screening instrument.
    Abuzinadah AR; Alkully HS; Alanazy MH; Alrawaili MS; Milyani HA; AlAmri B; AlShareef AA; Bamaga AK
    Medicine (Baltimore); 2021 Nov; 100(44):e27627. PubMed ID: 34871227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turkish version of the Michigan Neuropathy Screening Instrument in the assessment of diabetic peripheral neuropathy: a validity and reliability study.
    Kaymaz S; Alkan H; Karasu U; Çobankara V
    Diabetol Int; 2020 Jul; 11(3):283-292. PubMed ID: 32802710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the "QUICK" questionnaire--a tool for diagnosis of "wearing-off" in patients with Parkinson's disease.
    Martinez-Martin P; Tolosa E; Hernandez B; Badia X;
    Mov Disord; 2008 Apr; 23(6):830-6. PubMed ID: 18307246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.